NextPlat (NXPL) Net Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
NextPlat (NXPL) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 948.00 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -990.00 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -1,504.00 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 675.00 |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 787.00 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 427.00 |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -228,760.00 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -163.00 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 17,272.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 14,559.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,559.00 |
| Mar 31, 2026 | 2,993.00 |
| Dec 31, 2025 | -1,413.00 |
| Sep 30, 2025 | 20,128.00 |
| Jun 30, 2025 | 4,415.00 |
| Mar 31, 2025 | 981.00 |
| Dec 31, 2024 | 15,599.00 |
| Sep 30, 2024 | 7,502.00 |
| Jun 30, 2024 | 4,329.00 |
| Mar 31, 2024 | 4,762.00 |
| Dec 31, 2023 | 8,184.00 |
| Sep 30, 2023 | 9,714.00 |
| Jun 30, 2023 | -14,898.00 |
| Mar 31, 2023 | -2,187.00 |
| Dec 31, 2022 | -890.00 |
| Sep 30, 2022 | -19,979.00 |
| Jun 30, 2022 | -4,449.00 |
| Mar 31, 2022 | -552.00 |
| Dec 31, 2021 | -11,480.00 |
| Sep 30, 2021 | -7,907.00 |